Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MYRIAD GENETICS INC Director's Dealing 2012

Aug 21, 2012

32566_dirs_2012-08-21_e4751ada-ca03-433e-8ca9-92f6d0dfb8ec.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2012-08-20

Reporting Person: GILBERT WALTER PHD (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2012-08-20 Common Stock M 10000 $7.6 Acquired 10000 Direct
2012-08-20 Common Stock S 10000 $25.9424 Disposed 0 Direct
2012-08-20 Common Stock M 20000 $10.6 Acquired 20000 Direct
2012-08-20 Common Stock S 20000 $25.9424 Disposed 0 Direct
2012-08-20 Common Stock M 12802 $16.46 Acquired 12802 Direct
2012-08-20 Common Stock S 12802 $25.9424 Disposed 0 Direct
2012-08-21 Common Stock M 17198 $16.46 Acquired 17198 Direct
2012-08-21 Common Stock S 17198 $26.0972 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2012-08-20 Non-Qualified Stock Option (right to buy) $7.6 M 10000 Disposed 2016-01-06 Common Stock (10000) Direct
2012-08-20 Non-Qualified Stock Option (right to buy) $10.6 M 20000 Disposed 2016-11-16 Common Stock (20000) Direct
2012-08-20 Non-Qualified Stock Option (right to buy) $16.46 M 12802 Disposed 2017-11-15 Common Stock (12802) Direct
2012-08-21 Non-Qualified Stock Option (right to buy) $16.46 M 17198 Disposed 2017-11-15 Common Stock (17198) Direct

Footnotes

F1: One third vests annually beginning on the 1st anniversary of the option date.